• Share
  • Email
  • Print
Get Connected
FDA Alert

New FDA Rule on Drug Labeling May Mean Increased Exposure and an Uncertain Path for Generic Pharmaceutical Manufacturers

Michael H. Hinckle, James W. Matthews, Katy E. Koski, Jason L. Drori
15 November 2013

This publication/newsletter is for informational purposes and does not contain or convey legal advice. The information herein should not be used or relied upon in regard to any particular facts or circumstances without first consulting a lawyer. Any views expressed herein are those of the author(s) and not necessarily those of the law firm’s clients.